High Expression of SMO and GLI1 Genes with Poor Prognosis in Malignant Mesothelioma

Figure 4

Correlation between SMO expression levels and immune cells (CD4+ T cells, macrophages, B cells, CD8+ T cells, neutrophils, and dendritic cells) in malignant mesothelioma (a). Correlation between the level of GLI1 expression and 8 immune cells in malignant mesothelioma (b). Correlation between the level of immune cell infiltration and the survival prognosis of mesothelioma patients (c). Correlation between SMO gene expression and the survival prognosis of mesothelioma patients (d). This is the relationship between SMO copy number variation and immune cell infiltration in malignant mesothelioma (e). The degree of correlation between GLI1 gene expression and survival prognosis of mesothelioma patients (f). This is the relationship between GLI1 copy number variation and immune cell infiltration in malignant mesothelioma (g).

(a)

(b)

(c)

(d)

(e)

(f)

(g)